Cancer therapies targeted to the epidermal growth factor receptor and its family members

By Kane Susan E  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 2, 2006-02 ,pp. : 147-164

Informa Healthcare

Access to resources Recommend Favorite

Human papillomavirus 16 oncoprotein regulates the translocation of β-catenin via the activation of epidermal growth factor receptor

By Hu Zhongliang   Müller Susan   Qian Guoqing   Xu Jing   Kim Sungjin   Chen Zhengjia   Jiang Ning   Wang Dongsheng   Zhang Hongzheng   Saba Nabil F.   Shin Dong M.   Chen Zhuo Georgia  

Cancer, Vol. 121, Iss. 2, 2015-01 ,pp. : 214-225

Blackwell Publishing

Access to resources Recommend Favorite

Recent Advances in Drug Design of Epidermal Growth Factor Receptor Inhibitors

By  

Current Medicinal Chemistry, Vol. 20, Iss. 16, 2013-05 ,pp. : 2043-2067

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Sustained-release Carrier of NanoAg-Epidermal Growth Factor in Promoting Refractory Diabetic Wound Healing

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 2, 2016-02 ,pp. : 135-140

Bentham Science Publishers

Access to resources Recommend Favorite

Sustained Release Drug Delivery to the Lungs: An Option for the Future

By Hardy J.G.   Chadwick T.S.  

Clinical Pharmacokinetics, Vol. 39, Iss. 1, 2000-07 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite